Effect of polysulfated glycosaminoglycan on DNA content and proteoglycan metabolism in normal and osteoarthritic canine articular cartilage explants

Veterinary Surgery

Volumn 29, Issue 5, 2000, Pages 407-414

  Sevalla, Katherine ^a,b   Todhunter, Rory J ^a,b   Vernier Singer, Margaret ^a,b   Budsberg, Steven C ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

A73025; DNA; GLYCOSAMINOGLYCAN; PROTEOGLYCAN;

ANIMAL; ANIMAL DISEASE; ARTICLE; ARTICULAR CARTILAGE; BIOSYNTHESIS; DOG; DOG DISEASE; DRUG EFFECT; HINDLIMB; KNEE OSTEOARTHRITIS; METABOLISM; PATHOLOGY;

ANIMALS; CARTILAGE, ARTICULAR; DNA; DOG DISEASES; DOGS; GLYCOSAMINOGLYCANS; OSTEOARTHRITIS, KNEE; PROTEOGLYCANS; STIFLE;

EID: 0034266941     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1053/jvet.2000.9139     Document Type: Article

References (39)

1. Osteoarthritis: Challenges for the 21st Century. J Rheumatol 22:43, 1995
2. McIlwraith CW: General pathobiology of the joint and response to injury, in Mcllwraith CW, Trotter GW (eds): Joint Disease in the Horse. Philadelphia, PA, Saunders, 1996, pp 40-69
3. Nguyen Q, Murphy G, Roughley RJ, et al: Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. Biochem J 259:61-67, 1989
4. Wu J-J, Lark MW, Chun LE, et al: Molecular sites of stromelysin cleavage in collagen types II, IX, X and XI of cartilage. J Biol Chem 266:5625-5628, 1991
5. Okada Y, Konomi H, Toshikazu Y, et al: Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. Federation of European Biochemical Societies Letters 244:473-476, 1989
6. Nagase H, Woessner JF: Role of endogenous proteinases in the degradation of cartilage matrix, in Woessner JF, Howell LDS (eds): Joint Cartilage Degradation. Basic and Clinical Aspects. New York, Marcel Dekker, 1993, pp 159-185
7. McNamara PS, Johnston SA, Todhunter RJ: Slow-acting disease-modifying osteoarthritis agents. Vet Clin North Am Small Anim Pract 27:863-881, 1997
8. Todhunter RJ, Lust G: Polysulfated glycosaminoglycan in the treatment of osteoarthritis. J Am Vet Med Assoc 204:1245, 1994
9. Trotter GW: Polysulfated glycosaminoglycan, in McIlwraith CW, Trotter GW (eds): Joint Disease in the Horse. Philadelphia, PA, Saunders, 1996, pp 270-280
10. 12 supplemented with insulin and calcium: Effects of addition of TGF-β. Arch Biochem Biophys 283:27-33, 1990
11. Howell DS, Carreno MR, Pelletier J-P, et al: Articular cartilage breakdown in a lapine model of osteoarthritis: Action of glycosaminoglycan polysulfate ester (GAGPS) on proteoglycan degrading enzyme activity, hexuronate, and cell counts. Clin Orthop 213:69-76, 1986
12. Farndale RW, Buttle DJ, Barret AJ: Improved quantitation and discrimination of sulfated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta 883:173-177, 1986
13. Rao J, Otto WR: Fluorimetric DNA assay for cell growth estimation. Anal Biochem 207:186-192, 1992
14. Budsberg SC, Thomas EJ-MA: Temporal evaluation of ground reaction forces, keratan sulfate and hyaluronate in dogs with transected cranial cruciate ligaments. Vet Surg 27:502, 1998
15. Vasseur PB: Stifle joint, in Slatter D (ed): Textbook of Small Animal Surgery, vol 2. Philadelphia, PA, Saunders, 1993, pp 1817-1865
16. Burton-Wurster N, Todhunter RJ, Lust G: Animal models of osteoarthritis, in Woessner JF Jr, Howell DS (eds): Joint Cartilage Degradation. New York, Marcel Dekker, 1993, pp 347-384
17. Eyre DR, McDevitt CA, Billingham ME, et al: Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 288:823-837, 1980
18. Matyas JR, Adams ME, Huang D, et al: Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis Rheum 38:420-425, 1995
19. Adams ME, Matyas JR, Huang D, et al: Expression of proteoglycans and collagen in the hypertrophic phase of experimental osteoarthritis. J Rheumatol 22:94-97, 1995
20. Todhunter RJ, Fubini SL, Vernier-Singer M, et al: Acute synovitis and intra-articular methylprednisolone acetate in ponies. Osteoarthritis Cartilage 6:94-105, 1998
21. MacLeod JN, Fubini SL, Gu DN, et al: Effect of synovitis and corticosteroids on transcription of cartilage matrix protein. Am J Vet Res 59:1021-1026, 1998
22. Gardner DL: Articular cartilage samples, in Maroudas A, Kuettner K (eds): Methods in Cartilage Research. London, Academic Press, 1990, pp 4-6
23. Todhunter RJ: Anatomy and physiology of synovial joints, in McIlwraith CW, Trotter GW (eds): Joint Disease in the Horse. Philadelphia, PA, Saunders, 1996, pp 1-28
24. Palmer JL, Bertone AL: Joint biomechanics in the pathogenesis of traumatic arthritis, in McIlwraith CW, Trotter GW (eds): Joint Disease in the Horse. Philadelphia, PA, Saunders, 1996, pp 104-119
25. Steinmeyer J, Burton-Wurster N, Lust G: Effects of three antiarthritic drugs on fibronectin and keratan sulfate synthesis by cultured canine articular cartilage chondrocytes. Am J Vet Res 53:2077-2083, 1992
26. Todhunter RJ, Fubini SL, Wootton JAM, et al: Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants. J Rheumatol 23:1207-1213, 1996
27. MacLeod JN, Fubini SL, Vernier-Singer M, et al: Corticosteroids suppress the differentiated phenotype of articular chondrocytes. Transactions of the Orthopedic Research Society, 45th Annual Meeting, Anaheim, CA, Feb 1-4, 1999, p 131 (abstr)
28. Caron JP, Toppin DS, Block JA: Effect of polysulfated glycosaminoglycan on osteoarthritic equine articular cartilage in explant culture. Am J Vet Res 54:1116-1121, 1993
29. Von der Mark K, Frischholz S, Aigner T, et al: Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop Scand Suppl 266:125-129, 1995
30. Girkomtainde I, Frischholz S, Lammi P, et al: Immunolocalization of type X collagen in normal fetal and adult articular cartilage with monoclonal antibodies. Matrix Biol 15:231-238, 1996
31. Yang C, Li SW, Helminen HJ, et al: Apoptosis of chondrocytes in transgenic mice lacking collagen II. Exp Cell Res 235:370-373, 1997
32. Hashimoto S, Ochs RL, Rosen R, et al: Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci 95:3094-3099, 1998
33. Hashimoto H, Tanaka M, Suda T, et al: Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 41:657-662, 1998
34. Yovich JV, Trotter GW, McIlwraith CW, et al: Effects of polysulfated glycosaminoglycan on chemical and physical defects in equine articular cartilage. Am J Vet Res 48:1407-1414, 1987
35. Annefeld M, Erne B, Rasser Y: Ultrastructural analysis of rat articular cartilage following treatment with dexamethasone and glycosaminoglycan-peptide complex. Clin Exp Rheumatol 8:151-157, 1990
36. Carreno MR, Muniz OE, Howell DS: The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental osteoarthritis: Effects on morphological variables of disease severity. J Rheumatol 13:490-497, 1986
37. Hannan N, Ghosh P, Bellenger C, et al.: Systemic administration of glycosaminoglycan polysulphate (arteparon) provides partial protection of articular cartilage from damage produced by meniscectomy in the canine. J Orthop Res 5:47-59, 1987
38. Altman RD, Dean DD, Muniz OE, et al.: Therapeutic treat-ment of canine osteoarthritis with glycosaminoglycan polysulfuric acid ester. Arthritis Rheum 32:1300-1307, 1989
39. Glade MJ: Polysulfated glycosaminoglycan accelerates net synthesis of collagen and glycosaminoglycans by arthritic equine cartilage tissues and chondrocytes. Am J Vet Res 51:779-785, 1990